Image 1 of 1
VIP 10 MG
Core Focal Point: Multi-System Homeostasis, Pulmonary Vasodilation, and Metabolic Modulation.
1. Molecular Structure & Origin
VIP is an endogenous 28-amino acid neuropeptide originally isolated from the gastrointestinal tract but widely produced throughout the central and peripheral nervous systems.
The Superfamily: It belongs to the glucagon/secretin hormone superfamily.
Receptor Pathways: It exerts its biological actions by binding to two primary G-protein coupled receptors: VPAC1 and VPAC2.
2. 🎯 The Metabolic & Fat-Burning Nuance (How it Differs from Tesamorelin)
If Tesamorelin is a blunt hammer for fat burning, VIP is a subtle dial. Its relationship with fat regulation and body composition is complex and systemic:
The VIP/VPAC2R Anti-Obesity Pathway
Emerging animal model research (such as Diet-Induced Obesity or DIO models) indicates that activation of the VIP/VPAC2R pathway helps inhibit body fat mass accumulation while carefully preserving lean muscle tissue.
The Lipolysis & Glycogenolysis.
When VIP binds to receptors on adipocytes (fat cells) and hepatocytes (liver cells), it stimulates adenylate cyclase, raising intracellular cAMP levels.
In Fat Cells: This triggers a mild lipolytic effect, breaking down triglycerides into free fatty acids.
In the Liver: It stimulates glycogenolysis (breaking down stored glycogen into glucose), managing systemic energy allocation.
The Obesity Downregulation Paradox
Clinical data shows that individuals with abnormally high or deregulated baseline VIP levels often present with altered lipid profiles, establishing a direct, albeit complex, correlation between VIP homeostasis and healthy triglyceride metabolism.
3. 🫁 Primary Non-Fat Targets (Its True Clinical Power)
In a clinic or classroom, VIP is rarely discussed solely as a "fat burner." Its primary therapeutic applications target entirely different biological systems:
Pulmonary Hypertension & Vasodilation: VIP is a potent smooth muscle relaxant. In clinical settings, aerosolized (inhaled) VIP is heavily studied to selectively dilate pulmonary blood vessels, drastically improving exercise capacity in patients suffering from Primary Pulmonary Hypertension (PPH).
The Biotoxin/CIRS Protocol: In functional medicine, VIP nasal sprays are frequently used to treat Chronic Inflammatory Response Syndrome (CIRS) (often caused by mold exposure or Lyme disease). It works by downregulating inflammatory cytokines and crossing the blood-brain barrier to restore normal hypothalamic function.
Gut-Immune Homeostasis: VIP serves as a cornerstone of the enteric nervous system. It maintains immunological tolerance in the gut, protects the epithelial barrier, and regulates T-cell responses to prevent autoimmune flares.
🛡️ Clinical Spotlight: VIP in Auto-Immunity (Crohn's & Rheumatoid Arthritis)
Vasoactive Intestinal Peptide (VIP) is currently a major focus in advanced immunology because it serves as a natural, endogenous shield against tissue destruction. Rather than broadly wiping out the immune system like traditional drugs, VIP actively retrains it to stop attacking the body.
1. VIP & Crohn’s Disease (Gut Lining Protection)
Crohn’s disease occurs when hyper-active immune cells attack the gastrointestinal tract, causing severe ulcers and painful tissue scarring.
The VIP Rescue: VIP stabilizes the delicate gut barrier, keeping the intestinal wall tightly sealed to stop toxic leaks.
Preventing Blockages: It suppresses specific adhesion molecules (like ICAM-1) in colon cells, which prevents the chronic, painful tissue scarring and intestinal blockages common in Crohn's patients.
Intestinal Barrier Support: VIP actively repairs and stabilizes the tight junctions of the gastrointestinal epithelial wall, preventing the "leaky gut" effect that allows toxins to spill into the blood.
Halting Strictures:VIP suppresses specific adhesion molecules like ICAM-1, directly preventing the formation of deep tissue scars and blockages in the colon.
Inflammation Control: In landmark preclinical research, VIP administration completely abrogated diarrhea, weight loss, and tissue damage by cutting off inflammatory cytokines directly in colon extracts.
2. VIP & Rheumatoid Arthritis (Joint & Bone Protection)
Rheumatoid Arthritis (RA) is an autoimmune attack where immune cells invade joint fluid, eroding bone and destroying cartilage.
The VIP Rescue: Landmark clinical research shows that VIP can completely abrogate (halt) joint swelling, cartilage degradation, and bone erosion.
Calming the Joint Fluid: It forces destructive, pro-inflammatory T-cells inside the joints to transform into peaceful, tissue-healing cells instead.
The Biomarker Proof: Human data shows that arthritis patients born with naturally lower baseline levels of VIP suffer from significantly faster, more aggressive joint destruction.
Abrogating Symptoms: Groundbreaking studies highlighted by the Johns Hopkins Arthritis Centerfound that VIP can completely abrogate joint swelling, cartilage damage, and bone erosion.
Immune Retraining: It downregulates destructive Th1 and Th17 cell paths while upregulating peaceful, tissue-healing Th2 cell paths within joint fluids.
The Biomarker Link: Human trials tracking patients with early arthritis discovered that those with lower baseline levels of VIP suffered from a significantly more aggressive disease course, showing that VIP acts as the body's natural defensive shield.
Product Details:
• Compound: VIP
• Quantity: 10 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture
Research Use Only
This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.
This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.
By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.
Core Focal Point: Multi-System Homeostasis, Pulmonary Vasodilation, and Metabolic Modulation.
1. Molecular Structure & Origin
VIP is an endogenous 28-amino acid neuropeptide originally isolated from the gastrointestinal tract but widely produced throughout the central and peripheral nervous systems.
The Superfamily: It belongs to the glucagon/secretin hormone superfamily.
Receptor Pathways: It exerts its biological actions by binding to two primary G-protein coupled receptors: VPAC1 and VPAC2.
2. 🎯 The Metabolic & Fat-Burning Nuance (How it Differs from Tesamorelin)
If Tesamorelin is a blunt hammer for fat burning, VIP is a subtle dial. Its relationship with fat regulation and body composition is complex and systemic:
The VIP/VPAC2R Anti-Obesity Pathway
Emerging animal model research (such as Diet-Induced Obesity or DIO models) indicates that activation of the VIP/VPAC2R pathway helps inhibit body fat mass accumulation while carefully preserving lean muscle tissue.
The Lipolysis & Glycogenolysis.
When VIP binds to receptors on adipocytes (fat cells) and hepatocytes (liver cells), it stimulates adenylate cyclase, raising intracellular cAMP levels.
In Fat Cells: This triggers a mild lipolytic effect, breaking down triglycerides into free fatty acids.
In the Liver: It stimulates glycogenolysis (breaking down stored glycogen into glucose), managing systemic energy allocation.
The Obesity Downregulation Paradox
Clinical data shows that individuals with abnormally high or deregulated baseline VIP levels often present with altered lipid profiles, establishing a direct, albeit complex, correlation between VIP homeostasis and healthy triglyceride metabolism.
3. 🫁 Primary Non-Fat Targets (Its True Clinical Power)
In a clinic or classroom, VIP is rarely discussed solely as a "fat burner." Its primary therapeutic applications target entirely different biological systems:
Pulmonary Hypertension & Vasodilation: VIP is a potent smooth muscle relaxant. In clinical settings, aerosolized (inhaled) VIP is heavily studied to selectively dilate pulmonary blood vessels, drastically improving exercise capacity in patients suffering from Primary Pulmonary Hypertension (PPH).
The Biotoxin/CIRS Protocol: In functional medicine, VIP nasal sprays are frequently used to treat Chronic Inflammatory Response Syndrome (CIRS) (often caused by mold exposure or Lyme disease). It works by downregulating inflammatory cytokines and crossing the blood-brain barrier to restore normal hypothalamic function.
Gut-Immune Homeostasis: VIP serves as a cornerstone of the enteric nervous system. It maintains immunological tolerance in the gut, protects the epithelial barrier, and regulates T-cell responses to prevent autoimmune flares.
🛡️ Clinical Spotlight: VIP in Auto-Immunity (Crohn's & Rheumatoid Arthritis)
Vasoactive Intestinal Peptide (VIP) is currently a major focus in advanced immunology because it serves as a natural, endogenous shield against tissue destruction. Rather than broadly wiping out the immune system like traditional drugs, VIP actively retrains it to stop attacking the body.
1. VIP & Crohn’s Disease (Gut Lining Protection)
Crohn’s disease occurs when hyper-active immune cells attack the gastrointestinal tract, causing severe ulcers and painful tissue scarring.
The VIP Rescue: VIP stabilizes the delicate gut barrier, keeping the intestinal wall tightly sealed to stop toxic leaks.
Preventing Blockages: It suppresses specific adhesion molecules (like ICAM-1) in colon cells, which prevents the chronic, painful tissue scarring and intestinal blockages common in Crohn's patients.
Intestinal Barrier Support: VIP actively repairs and stabilizes the tight junctions of the gastrointestinal epithelial wall, preventing the "leaky gut" effect that allows toxins to spill into the blood.
Halting Strictures:VIP suppresses specific adhesion molecules like ICAM-1, directly preventing the formation of deep tissue scars and blockages in the colon.
Inflammation Control: In landmark preclinical research, VIP administration completely abrogated diarrhea, weight loss, and tissue damage by cutting off inflammatory cytokines directly in colon extracts.
2. VIP & Rheumatoid Arthritis (Joint & Bone Protection)
Rheumatoid Arthritis (RA) is an autoimmune attack where immune cells invade joint fluid, eroding bone and destroying cartilage.
The VIP Rescue: Landmark clinical research shows that VIP can completely abrogate (halt) joint swelling, cartilage degradation, and bone erosion.
Calming the Joint Fluid: It forces destructive, pro-inflammatory T-cells inside the joints to transform into peaceful, tissue-healing cells instead.
The Biomarker Proof: Human data shows that arthritis patients born with naturally lower baseline levels of VIP suffer from significantly faster, more aggressive joint destruction.
Abrogating Symptoms: Groundbreaking studies highlighted by the Johns Hopkins Arthritis Centerfound that VIP can completely abrogate joint swelling, cartilage damage, and bone erosion.
Immune Retraining: It downregulates destructive Th1 and Th17 cell paths while upregulating peaceful, tissue-healing Th2 cell paths within joint fluids.
The Biomarker Link: Human trials tracking patients with early arthritis discovered that those with lower baseline levels of VIP suffered from a significantly more aggressive disease course, showing that VIP acts as the body's natural defensive shield.
Product Details:
• Compound: VIP
• Quantity: 10 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture
Research Use Only
This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.
This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.
By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.